公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2015 | Rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Taiwanese treatment experienced hepatitis C virus genotype 1-infected patients | Yang C.-C.; Tsai W.-L.; Su W.-W.; Huang C.-F.; Cheng P.-N.; Lo C.-C.; Tseng K.-C.; Mo L.-R.; Wang C.-H.; SHIH-JER HSU ; Lai H.-C.; Su C.-W.; CHUN-JEN LIU ; Peng C.-Y.; Yu M.-L. | PLoS ONE | 8 | 5 | |
2010 | The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; DING-SHINN CHEN ; JIA-HORNG KAO | Kidney International | 31 | 32 | |
2009 | Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy | TAI-CHUNG TSENG ; CHUN-JEN LIU ; SONG-CHOU HSIEH ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Digestive and Liver Disease | 3 | 3 | |
2018 | Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 25 | 24 | |
2018 | Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | PLoS ONE | 11 | 10 | |
2020 | Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data | CHUN-MING HONG ; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; Chen Y.-W; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of Microbiology, Immunology and Infection | 18 | 18 | |
2020 | Relationship between serum gamma-glutamyl transferase level and colorectal adenoma | TZU-CHAN HONG ; HUNG-CHIH YANG ; CHI-LING CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU ; Chen M.-J; Wang H.-Y; Kuo Y.-C; Yu L.-Y; Hu K.-C. | PLoS ONE | 4 | 2 | |
1990 | Remission induction of ANLL with low dose cytosine arabinoside combined with retinoic acid. | Chen P.M.; Hsieh R.K.; Chuang M.W.; Liu J.H.; Fan S.; CHUN-JEN LIU ; Tzeng C.H. | Zhonghua yi xue za zhi = Chinese medical journal; Free China ed | 0 | 0 | |
2007 | Reply [2] | Lin C.-L.; CHUN-JEN LIU ; JIA-HORNG KAO | Hepatology | 0 | 0 | |
2006 | Reply [2] | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 0 | 0 | |
2006 | Reply [3] | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 0 | 0 | |
2003 | Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; YUNG-MING JENG ; DING-SHINN CHEN | Hepatology | 118 | 94 | |
2001 | Risk factors for ICU mortality in critically ill patients | YEE-CHUN CHEN ; Lin S.-F.; CHUN-JEN LIU ; Jiang D.D.-S.; PAN-CHYR YANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association | 42 | 42 | |
2013 | Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Yang W.-T; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 45 | 44 | |
2012 | The risky body mass index ranges for significant hepatitis B viral load: A campus-based study | CHIEN-HSIEH CHIANG ; Lai J.-S.; JIN-CHUAN SHEU ; Yen L.-L.; CHUN-JEN LIU ; KUO-CHIN HUANG | Obesity Research and Clinical Practice | 13 | 13 | |
2005 | RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant | Wu H.-L.; Huang L.-R.; Huang C.-C.; Lai H.-L.; CHUN-JEN LIU ; Huang Y.-T.; Hsu Y.-W.; Lu C.-Y.; DING-SHINN CHEN ; PEI-JER CHEN | Gastroenterology | 96 | 93 | |
2006 | Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers | CHUN-JEN LIU ; Chen B.-F.; PEI-JER CHEN ; Lai M.-Y.; Huang W.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Infectious Diseases | 161 | 142 | |
2003 | Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related Risk | MING-WHEI YU ; Chang H.-C.; Chang S.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; PEI-JER CHEN ; Lin S.-C.; Chen C.-J. | Hepatology | 158 | 127 | |
2007 | Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7] | TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | American Journal of Gastroenterology | 1 | 1 | |
2023 | Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months | TUNG-HUNG SU ; Chang, Shan-Han; CHI-LING CHEN ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology research : the official journal of the Japan Society of Hepatology | 1 | 0 |